Remdesivir for the Treatment of Covid-19 — Preliminary Report

Abstract Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), none have yet been shown to be efficacious. We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults hospitalized with Covid-19 […]

Click here to view original web page at Remdesivir for the Treatment of Covid-19 — Preliminary Report